Document is current
Any future updates will be listed below
-
Authors
Lambert, Samuel A. https://orcid.org/0000-0001-8222-008X
Gil, Laurent https://orcid.org/0000-0002-9475-4502
Jupp, Simon
Ritchie, Scott C. https://orcid.org/0000-0002-8454-9548
Xu, Yu https://orcid.org/0000-0002-7304-5045
Buniello, Annalisa
McMahon, Aoife https://orcid.org/0000-0003-0978-0309
Abraham, Gad
Chapman, Michael https://orcid.org/0000-0002-4582-6303
Parkinson, Helen
Danesh, John
MacArthur, Jacqueline A. L. https://orcid.org/0000-0002-3550-9769
Inouye, Michael https://orcid.org/0000-0001-9413-6520
-
Funding
Funding for this research was provided by:
Baker IDI Heart and Diabetes Institute (Munz Chair, CBSGI, CBSGI, CBSGI, CBSGI)
Gouvernement du Canada | Canadian Institutes of Health Research (MFE-171279)
Health Data Research UK
European Bioinformatics Institute
British Heart Foundation (Professorship)
- License Information
-
More Information
Article History
First Online: 10 March 2021
Competing interests
: J.D. is part of the International Cardiovascular and Metabolic Advisory Board for Novartis (since 2010); the Steering Committee of UK Biobank (since 2011); the MRC International Advisory Group (ING), London (since 2013); the MRC High Throughput Science Omics Panel, London (since 2013); the Scientific Advisory Committee for Sanofi (since 2013); the International Cardiovascular and Metabolism Research and Development Portfolio Committee for Novartis; and the Astra Zeneca Genomics Advisory Board (2018).
